IP Verse

Nutraceutical Or Pharmaceutical Composition For Use In The Treatment Of Polycystic Ovary Syndrome Or Of Diseases Or Disorders Related Thereto - EP3452012B1

PatentPatent Analysis

EP3452012

S&R FARMACEUTICI
Application Number
EP17727376A
Filing Date
Apr 13, 2017
Status
Opposition Rejected
Feb 9, 2024
Grant Date
Jun 23, 2021
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3452012B1 was granted to S&R Farmaceutici on Jun 23, 2021 following the initial filing on Apr 13, 2017 under the application number EP17727376A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LOLI PHARMAMar 22, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents